Q2 2023
Released Aug 10, 2023, before the open
10-Q filed Aug 11, 2023, 42 days after period end · 0000868278-23-000014
Q2 2023 · 10-Q
Revenue$13.22M$13.22M −54.6% vs Q2 2022−31.5% vs Q1 2023
Net Income-$3.44M-$3.44M N/M vs Q2 2022N/M vs Q1 2023
EPS Diluted-$0.20-$0.20 N/M vs Q2 2022N/M vs Q1 2023
Gross Profit$6,448,000−65.6%
Operating Income-$4,658,000N/M
Operating Cash Flowderived-$6,957,000N/M
Free Cash Flowderived-$7,617,000N/M
Margins · derived
Gross margin48.8%−15.6 pt vs Q2 2022
Operating margin-35.2%−71.6 pt vs Q2 2022
Net margin-26.0%−51.6 pt vs Q2 2022
What the release said
The release
Same quarter
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $13.22M | $29.09M | $9.14M | $3.62M |
| Net Income | -$3.44M | $7.45M | -$1.40M | $70.00K |
| EPS Diluted | -$0.20 | $0.40 | -$0.09 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR